Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,990 stories, page 630 of 750

Advanced search

🇺🇸Jun 29CDMOinvestors.emergentbiosolutions.comTier 2 · Direct publisher

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Emergent BioSolutionsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

4D Molecular (FDMT) Completes Enrollment for Phase 3 Clinical Tr

GuruFocusOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biotech Pre-Market Pulse: UPC, DCOY, JUNS Post Sharp Moves

RTTNewsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA Approves COVID-19 Antiviral Xocova as PEP. But Will It Be Accessible?

poz.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Replimune gets FDA review for melanoma drug after prior setbacks

The Pharma LetterOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock?

Yahoo FinanceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

First Patients Treated via FDA-Cleared Transcranial Magnetic Stimulation, Plus FDA Grant on D-Cycloserine-Based Drug for Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

Barchart.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Helus Pharma reports Phase 3 trial progress, closes $50M offering By Investing.com

Investing.com IndiaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher

ACCESS NewswireOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biodexa's FAP trial expands into Canada as enrolment hits 73

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA rare pediatric disease designation could speed a measles drug review

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting

The Manila TimesOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Eli Lilly (LLY) Stock Hits Record High After European Drug Approval and Medicare Expansion

BlockonomiOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Thailand and U.S. strengthen cooperation on produce pesticide testing

FreshPlazaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Zhejiang Huahai Pharmaceutical to Sell Off Financial Assets

MoomooOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD

The Manila TimesOriginal source

🇫🇷Jun 29Regulatoryleem.orgTier 1 · Regulatory source

Plus de 109 tonnes de produits de santé mobilisées depuis le début de l’année 2026

LEEM FranceOriginal source

🇨🇦Jun 29Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Abiomed Introducer Kits with Impella Heart Pumps

Abiomed has initiated a voluntary medical device recall (correction) for all currently distributed I...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

4DMT finishes Phase 3 enrollment for wet AMD gene therapy trial

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD

GlobeNewswireOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

UK-based Scancell bids to buy Nasdaq-listed Neuphoria to ‘increase profile’ with US investors

Fierce BiotechOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Viatris (VTRS) Reports Positive Phase 3 Trial Results for VR-205

GuruFocusOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA recalls heart and blood pressure drugs over safety concerns

MSNOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Reports Recent Business Highlights and Fiscal Year 2026 Financial Results

GlobeNewswireOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

PharmTech Explained: Human Accountability with AI in GMP

PharmTech.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

PR NewswireOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Biohaven's BHV-1300 targets the root cause of Graves' disease in Phase 3

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0

TradingViewOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Dianthus launches phase 3 trial for myasthenia gravis treatment By Investing.com

Investing.com CanadaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Anivive Wins Full U.S. FDA Approval for Laverdia, First At-Home Oral Treatment for Canine Lymphoma

BioPharma APACOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Zymeworks to acquire troubled biotech Theravance in $929M deal

Endpoints NewsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

The Manila TimesOriginal source

🌍Jun 29Industryrelmada.comTier 1 · Company source

Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes

Relmada TherapeuticsOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Dianthus launches Phase 3 study of claseprubart in rare muscle disease

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

'There's room for multiple winners': Talawar heads to Nasdaq via SPAC deal to bankroll eczema asset

Fierce BiotechOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Artivion’s AMDS gets FDA approval for deadly aortic tears

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 2 · Trade media

Biogen trims Apellis pipeline and R&D team after $5.6bn takeover

Pharmaceutical TechnologyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Viatris kidney drug VR-205 cut protein in urine 33.75% in Japan

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Inc.(NasdaqGS:RARE) added to Russell 2000 Growth Benchmark

marketscreener.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Sun Pharmaceutical Industries rises Monday, outperforms market

MarketWatchOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Larimar says FDA can review nomlabofusp for accelerated approval

Stock TitanOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Yelin Lapidot Holdings Management Ltd. Decreases Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Natera partners with Aveta for phase 3 head and neck cancer trial

Investing.comOriginal source

🇩🇰Jun 29Regulatorylaegemiddelstyrelsen.dkTier 1 · Regulatory source

Are you running clinical trials? You can now activate e-mail notifications in CTIS

Danish Medicines AgencyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer

LelezardOriginal source

🇿🇦Jun 29Researchsu.ac.zaTier 3 · Secondary coverage

Building community through multilingualism at SU Teaching-Learning-Assessment Day

Stellenbosch UniversityOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Sandoz submits generic obesity drug applications to FDA By Investing.com

Investing.com UKOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Sandoz submits generic obesity drug applications to FDA

Investing.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Samsung Bioepis First to Prove Equivalence in Phase 3 Trial for Keytruda Biosimilar, Targeting $29.8 Billion Market

BigGo FinanceOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Building an AI-native pharmaceutical enterprise: Lupin’s blueprint for intelligent transformation - Lupin | Perspective

lupin.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Natera partners with Aveta for phase 3 head and neck cancer trial By Investing.com

Investing.com IndiaOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA Clears Pen Device for Interferon Therapy in Polycythemia Vera

Targeted OncologyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Goldenwell Biotech (GWLL) restates Q3 2025 and flags going concern

Stock TitanOriginal source

🇨🇦Jun 29Industryir.zymeworks.comTier 1 · Company source

Zymeworks to Acquire Theravance Biopharma, Inc.

ZymeworksOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Natera joins Aveta's global Phase 3 head and neck cancer trial

Stock TitanOriginal source

🌍Jun 29Industrypiindustries.comTier 1 · Company source

PI Industries Ltd, Udaipur has received the International Safety Award 2026 in Distinction Category by British Safety Council

PI Industries (Pharma)Original source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

Thai FDA and US Officials Convene to Tighten Pesticide Checks on Imported Produce

Nation ThailandOriginal source

🇺🇰Jun 29Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 27 report: data to week 26 (data up to 28 June 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

China ‘emerging a global leader’ in biotech business

chinadailyasia.comOriginal source

🌍Jun 29discoverynews.google.comTier 3 · Aggregated media

FDA names former pharmaceutical company executive to oversee US drug program

MSNOriginal source